| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/20/2003 | CA2455761A1 Artichoke leaf extracts |
| 02/20/2003 | CA2455391A1 Nutritional supplements and methods of using same |
| 02/19/2003 | EP1284139A1 Novel fatty acid analogues for the treatment of fatty liver |
| 02/19/2003 | EP1283828A1 Novel polymorph v of torasemide |
| 02/19/2003 | EP0930870B1 Preparation protecting skin from mechanical irritation |
| 02/19/2003 | EP0774969B1 Hiv protease inhibitor combination |
| 02/19/2003 | CN1397282A Blood flor anendment, thrombus preventer or medicines |
| 02/19/2003 | CN1101695C Application of medicine from plant extracts for treatment of increase bone resorption, and compsns, thereof |
| 02/18/2003 | US6521632 Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor |
| 02/18/2003 | US6521270 Compositions comprising nitrofurantoin and uva ursi |
| 02/18/2003 | US6521260 Carrier particles for use in dry powder inhalers |
| 02/18/2003 | US6521253 Low molecular weight peptide thrombin inhibitor having pH dependent solubility and a combination of microcrystalline cellulose and sodium starch glycollate |
| 02/18/2003 | US6521238 Composition containing an opacifier or pearlescent agent and at least one fatty alcohol |
| 02/18/2003 | CA2351004C Formulation |
| 02/13/2003 | WO2003011277A2 Methods to mobilize progenitor/stem cells |
| 02/13/2003 | WO2003011228A2 Purification and crystalline forms of zaleplon |
| 02/13/2003 | WO2003011217A2 Grifola extracts and methods of use thereof |
| 02/13/2003 | WO2002083079A3 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 02/13/2003 | WO2002078638A3 Morpholino imaging and therapy |
| 02/13/2003 | US20030033126 Modeling biological systems |
| 02/13/2003 | US20030032636 For the treatment of depression and other affective disorders. |
| 02/13/2003 | US20030031737 Medicinal composition and method of using it |
| 02/13/2003 | US20030031657 Stem cells and their use in transplantation |
| 02/13/2003 | CA2453751A1 Purification and crystalline forms of zapelon |
| 02/12/2003 | EP1283036A1 Dry powder for inhalation |
| 02/12/2003 | EP1282654A2 Anionic vinyl/dicarboxylic acid polymers and uses thereof |
| 02/12/2003 | EP1282609A2 Piperazinedione compounds |
| 02/12/2003 | EP1282392A1 Oral composition |
| 02/12/2003 | EP0912161B1 Dual component dentifrice composition for dental fluoridation |
| 02/12/2003 | EP0711154B1 Stabilized pharmaceutical composition containing bupropion |
| 02/12/2003 | CN1396831A Pharmaceutical preparation and method for treatment of diabetes |
| 02/12/2003 | CN1396827A Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/12/2003 | CN1101190C HIV protease inhibitor combination medicine |
| 02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518247 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 02/11/2003 | US6517866 Sertraline salts and sustained-release dosage forms of sertraline |
| 02/11/2003 | US6517819 Antiperspirant suspensions containing finely divided aluminium and zirconium, having better effectiveness and a process for their manufacture |
| 02/11/2003 | CA2277074C Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining |
| 02/11/2003 | CA2223726C Keratin fibre oxidation dye composition and dye process using the composition |
| 02/11/2003 | CA2222851C Keratin fibre oxidation dye composition and dye process using the composition |
| 02/11/2003 | CA2092284C Conditioning shampoo composition and method of preparing and using the same |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/06/2003 | WO2002049666A3 Mycoplasma hyopneumoniae bacterin vaccine |
| 02/06/2003 | WO2002039949A9 Platelet/leukocyte interaction assay and reagent therefor |
| 02/06/2003 | US20030027831 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases |
| 02/06/2003 | US20030027824 Pyrazolopyrimidinones for the treatment of female sexual dysfunction |
| 02/06/2003 | US20030026839 Melt-extrusion multiparticulates |
| 02/06/2003 | US20030026829 Analgesic patch |
| 02/06/2003 | US20030026763 Using water soluble dyes |
| 02/05/2003 | EP1281763A2 Early growth response-1 (EGR-1) transcription factor |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280912A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 02/05/2003 | EP1280535A1 Processes for preparing clarithromycin polymorphs |
| 02/05/2003 | EP1280531A1 Local anesthetic methods and kits |
| 02/05/2003 | EP1003486B1 Pharmaceutical compositions containing an effervescent acid-base couple |
| 02/05/2003 | CN1100545C Reinforcing sexual function coposition |
| 02/04/2003 | US6515128 Dissolving 6-hydroxy-3,4-dihydroquinolinone and a base in water; dissolving a 1-cyclohexyl-5- (4-halobutyl)-tetrazole in water-immiscible solvent, mixing aqueous phase and organic phase in presence of phase transfer catalyst; recovering |
| 02/04/2003 | US6515091 Anionic vinyl/dicarboxylic acid polymers and uses thereof |
| 02/04/2003 | US6514976 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/04/2003 | US6514536 Drug preparations for treating sexual dysfunction |
| 02/04/2003 | US6514490 Compositions containing an antifungal and a cationic agent |
| 02/04/2003 | CA2362539C Fluorocarbon aerosol medicaments |
| 02/04/2003 | CA2234930C Underarm compositions |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003007986A2 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 01/30/2003 | WO2003007912A2 Lyophilized formulation comprising olanzapine |
| 01/30/2003 | WO2002030394A3 Medicinal aerosol formulations |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | US20030022874 New 17-halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them |
| 01/30/2003 | US20030019053 Dye composition for keratin fibres, with a cationic direct dye and a substantive polymer |
| 01/30/2003 | CA2453260A1 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 01/30/2003 | CA2450437A1 1-phenylsulphonyl-1,3-dihydro-2h-indol-2-one derivatives, their preparation and their therapeutic application |
| 01/30/2003 | CA2448724A1 2-methyl-thieno-benzodiazepine lyophilized formulation |
| 01/29/2003 | EP1279395A1 Composition for oxidative dyeing of keratinous fibres containing a fatty alcohol mono- or poly-glycerols and a particular polyol |
| 01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/29/2003 | EP1278411A1 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 01/29/2003 | CN1394141A Fulvestrant formulation |
| 01/29/2003 | CN1099893C Sustained-release preparation |
| 01/28/2003 | US6512116 No drug resistance; intravenous |
| 01/28/2003 | US6512009 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator |
| 01/28/2003 | US6511681 Solubility and bioavailability of azole antifungal medicaments |
| 01/28/2003 | US6511657 Antiperspirants and/or deodorants |
| 01/28/2003 | CA2284910C Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 01/28/2003 | CA2108369C Method and composition for ameliorating the adverse effects of aging |
| 01/28/2003 | CA2094300C Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
| 01/27/2003 | CA2395683A1 Compound for oxidation dying of keratin fibres containing a mono- or poly-glycerol fatty alcohol and a particular polyol |
| 01/23/2003 | WO2003006612A2 Production of transduced hematopoietic progenitor cells |
| 01/23/2003 | WO2003006430A1 Taxol enhancer compounds |
| 01/23/2003 | WO2003006428A1 Taxol enhancer compounds |
| 01/23/2003 | WO2003006064A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/23/2003 | US20030017220 Process for the extraction of valerian root |
| 01/23/2003 | US20030017209 Breath protection microcapsules |
| 01/23/2003 | US20030017171 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/23/2003 | CA2453187A1 Production of transduced hematopoietic progenitor cells |
| 01/23/2003 | CA2453111A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant |